The Venture Codex

Led · Series B · Dec 2025

Neubility is a robotics company focused on advancing ‘Physical AI’ technologies that enable its robots to perform practical tasks in daily settings. The firm emphasizes continual innovation, aiming to be “the first” in its field despite the obstacles inherent to pioneering work. With fresh capital in hand, Neubility plans to scale operations, expand its product lineup, and push its technology so its robots deliver real-world value to users worldwide. Leadership underscores a dual mandate to grow and generate revenue, viewing these goals as the essence of the business. The recent fund-raise lifts Neubility’s total capital to roughly $50 million, giving the team additional runway to accelerate R&D and commercialization plans. Although the company has not disclosed user or revenue figures, management’s comments suggest a commitment to measurable growth and broader market adoption.

Led · Series B · May 2025

Phoenix Tailings is developing the Freedom Facility, a fully integrated rare earth separation and metallization platform intended to produce both light and heavy rare earth metals from concentrates, recycled materials, and secondary sources. The company plans the facility to act as a midstream processing hub that can purchase output from mines and recyclers and supply materials to manufacturers and government entities. The project will use domestically controlled technology and intellectual property and aims to deliver cleaner, more efficient operations than conventional refining methods. Phoenix Tailings has targeted initial operations at the Freedom Facility for 2028. Financially, the company announced an approximately $1 billion financing initiative that includes a conditional $500 million long-term debt commitment from the U.S. Department of War’s Office of Strategic Capital to support construction and scaling of the facility.

Participated · Series B · Jul 2024

CastingN runs 업무마켓9, a combined business marketplace and procurement-management solution launched in 2021. 업무마켓9 aggregates over 30,000 suppliers and databases suppliers' items to help customers cut procurement costs by nearly 30%. Customers can access lowest-price purchasing and postpaid terms of up to KRW 100 million per month; the service has recorded more than 80,000 cumulative bids since launch. CastingN reported KRW 8 billion in annual revenue last year and says revenue grew by more than 95% year-over-year from 2020 through 2023. The company acquires over 200 new corporate customers annually and maintains a renewal rate above 85%. Management plans to use new funding to further optimize its indirect procurement management system, hire talent, and expand into large enterprises, targeting KRW 40 billion in annual revenue this year. Castingen operates a B2B platform that connects professional service providers with corporate buyers. The company positions itself as a way for specialist firms to win new customers through the platform. It also enables general companies to meet specialist suppliers reliably without having to build separate procurement or supply‑chain systems. Castingen plans to activate the B2B ecosystem by running buyer-focused initiatives, including free seminars to boost buyer engagement. Financially, Castingen recently secured investment funding of ₩4 billion. Participating investors include Magna Investment, Friend Investment Partners, The Wells Investment, and Hana Bank.

Led · Series C · Jun 2024

Welt is a digital therapeutics company whose insomnia product 'SleepQ' received MFDS approval last April and began its first domestic prescriptions on the 12th. The company is beginning commercialization with partner Handok and expects temporary reimbursement listing this year. Welt plans to accelerate global expansion starting in Germany, has research agreements with major German medical schools, is preparing local clinical trials, and signed a partnership with the German digital health association. Management says the new funding will speed domestic commercialization, fund pipeline R&D, and support international growth. The company is described as one of the fastest‑growing firms in the domestic digital therapeutics sector and is preparing to select an IPO underwriter. Including this round, Welt has raised a cumulative ₩28.0 billion.

Led · Series A · Mar 2024

테라클 produces high-purity recycled terephthalic acid (CR-TPA) and ethylene glycol by chemically recycling plastic, textile, and other hard-to-recycle wastes. The company successfully commercialized domestic-scale production of high-purity CR-TPA and holds a green-technology certification for its chemical depolymerization process, which showed about a 97% conversion rate. Its hydrolytic depolymerization runs at under 60°C and at atmospheric pressure, requiring significantly less energy than conventional high-temperature, high-pressure methods. 테라클 demonstrated its technical capabilities through a recycling demonstration with Hyundai’s AVP basic materials research center. The company aims to enable closed-loop resource circulation so customers can recycle manufacturing and process waste back into products. Proceeds from the recent financing will fund a depolymerization facility with an annual production capacity of 4,000 tons and expand recycling of wastes including discarded plastics, clothing, automotive parts, and marine debris.